Anglicheau D - Search Results

1

Long-term renal allograft outcome after simultaneous kidney and pancreas transplantation.

Rerolle JP, Thervet E, Anglicheau D, Desgrandchamps F, Nochy D, Janin A, Fornairon S, Passa P, Bedrossian J, Legendre C. Rerolle JP, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2002 May;17(5):905-9. doi: 10.1093/ndt/17.5.905. Nephrol Dial Transplant. 2002. PMID: 11981082

2

[Renal venous thrombosis: a forgotten complication of acute pyelonephritis].

Mamzer-Bruneel MF, Anglicheau D, Correas JM, Skhiri H, Jacobs F, Chrétien Y, Legendre C, Kreis H. Mamzer-Bruneel MF, et al. Among authors: anglicheau d. Presse Med. 1997 Sep 27;26(28):1334-6. Presse Med. 1997. PMID: 9365488 French.

3

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: anglicheau d. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

4

Clinical consequences of the polymorphism of azathioprine metabolism.

Thervet E, Anglicheau D, Toledano N, Kreis H, Legendre C, Beaune P. Thervet E, et al. Among authors: anglicheau d. Transplant Proc. 2000 Dec;32(8):2780. doi: 10.1016/s0041-1345(00)01882-0. Transplant Proc. 2000. PMID: 11134802 No abstract available.

5

Recent issues concerning renal transplantation in systemic lupus erythematosus patients.

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrol Dial Transplant. 2001 Jan;16(1):12-4. doi: 10.1093/ndt/16.1.12. Nephrol Dial Transplant. 2001. PMID: 11208985 Review. No abstract available.

6

[Pharmacology of mycophenolate mofetil: recent data and clinical consequences].

Thervet E, Anglicheau D, Legendre C. Thervet E, et al. Among authors: anglicheau d. Nephrologie. 2001;22(7):331-7. Nephrologie. 2001. PMID: 11817210 Review. French.

7

Thiopurine methyltransferase activity: new conditions for reversed-phase high-performance liquid chromatographic assay without extraction and genotypic-phenotypic correlation.

Anglicheau D, Sanquer S, Loriot MA, Beaune P, Thervet E. Anglicheau D, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 25;773(2):119-27. doi: 10.1016/s1570-0232(02)00130-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2002. PMID: 12031837

8

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.

Anglicheau D, Lautrette A, Scieux C, Thervet E, Martinez F, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Transplant Proc. 2002 Nov;34(7):2826-7. doi: 10.1016/s0041-1345(02)03531-5. Transplant Proc. 2002. PMID: 12431624 No abstract available.

9

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. J Am Soc Nephrol. 2003 Jul;14(7):1889-96. doi: 10.1097/01.asn.0000073901.94759.36. J Am Soc Nephrol. 2003. PMID: 12819250

10

Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.

Anglicheau D, Lautrette A, Scieux C, Flamant M, Morinet F, Legendre C. Anglicheau D, et al. Nephrol Dial Transplant. 2003 Aug;18(8):1654-6. doi: 10.1093/ndt/gfg251. Nephrol Dial Transplant. 2003. PMID: 12897109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters